JP2003527342A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003527342A5 JP2003527342A5 JP2001539455A JP2001539455A JP2003527342A5 JP 2003527342 A5 JP2003527342 A5 JP 2003527342A5 JP 2001539455 A JP2001539455 A JP 2001539455A JP 2001539455 A JP2001539455 A JP 2001539455A JP 2003527342 A5 JP2003527342 A5 JP 2003527342A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- glucocorticoid receptor
- receptor antagonist
- administration
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16743299P | 1999-11-23 | 1999-11-23 | |
| US60/167,432 | 1999-11-23 | ||
| PCT/US2000/032260 WO2001037840A1 (en) | 1999-11-23 | 2000-11-21 | Methods for treating mild cognitive impairment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003527342A JP2003527342A (ja) | 2003-09-16 |
| JP2003527342A5 true JP2003527342A5 (https=) | 2007-11-29 |
Family
ID=22607362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001539455A Pending JP2003527342A (ja) | 1999-11-23 | 2000-11-21 | 軽度認知障害を処置する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US6620802B1 (https=) |
| EP (1) | EP1242094A4 (https=) |
| JP (1) | JP2003527342A (https=) |
| AU (1) | AU778090B2 (https=) |
| CA (1) | CA2389570C (https=) |
| HK (1) | HK1047050A1 (https=) |
| WO (1) | WO2001037840A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010046470A1 (en) * | 2000-05-10 | 2001-11-29 | Kieko Morita | Diagnoses and treatment of disorders using an alternative glucose pathway |
| DE60232956D1 (de) | 2001-03-23 | 2009-08-27 | Corcept Therapeutics Inc | Verfahren zur behandlung von stressbedingten erkrankungen unter verwendung von glucocorticoid-rezepto-spezifischen antagonisten |
| NZ531477A (en) * | 2001-08-31 | 2006-10-27 | Corcept Therapeutics Inc | Use of a glucocorticoid receptor antagonist comprising a steroidal skeleton with at least one phenyl-containing moiety in the 11-beta position of the steroidal skeleton to decrease cognitive deterioration in adults with Down's syndrome |
| JP2005528395A (ja) * | 2002-04-05 | 2005-09-22 | ザ ユニバーシティ オブ エディンバラ | 組成物 |
| US8237946B2 (en) * | 2004-10-08 | 2012-08-07 | Sharp Laboratories Of America, Inc. | Methods and systems for imaging device accounting server redundancy |
| US20090156565A1 (en) * | 2004-12-03 | 2009-06-18 | The Children's Hospital Of Philadelphia | Composition and use thereof in enhancing a therapeutic effect of an antiepileptic drug |
| DK3260118T3 (da) * | 2008-10-16 | 2021-04-19 | Univ Johns Hopkins | Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion |
| US20110202284A1 (en) * | 2010-02-10 | 2011-08-18 | Mcreynolds Cristopher | Novel groups of biomarkers for diagnosing alzheimer's disease |
| US10500216B2 (en) | 2011-11-18 | 2019-12-10 | Corcept Therapeutics, Inc. | Optimizing mifepristone absorption |
| US20150290158A1 (en) * | 2012-11-09 | 2015-10-15 | Elliott C. Lasser | X-ray contrast media compositions and methods of using the same to treat, reduce or delay the onset of cns inflammation and inflammation associated conditions |
| US20140206667A1 (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
| WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| AU2014228512A1 (en) | 2013-03-15 | 2015-10-01 | Agenebio, Inc. | Methods and compositions for improving cognitive function |
| US9943526B2 (en) | 2015-04-21 | 2018-04-17 | Corcept Therapeutics, Inc. | Optimizing mifepristone levels for cushing's patients |
| CA2986598C (en) | 2015-05-22 | 2023-09-26 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3337450A1 (de) * | 1983-10-12 | 1985-04-25 | Schering AG, 1000 Berlin und 4709 Bergkamen | Prostaglandine und antigestagene fuer den schwangerschaftsabbruch |
| EP0954317B1 (en) | 1996-04-09 | 2007-06-06 | The University Of Edinburgh | Use of 7 apha-substituted steroids to treat neuropsychiatric disorders |
| AU747956B2 (en) * | 1997-10-06 | 2002-05-30 | Board Of Trustees Of The Leland Stanford Junior University | Methods for treating psychosis associated with glucocorticoid related dysfunction |
| IL139672A (en) * | 1998-05-15 | 2005-11-20 | Univ Leland Stanford Junior | Glucocorticoid receptor antagonists for the tretment of dementia |
-
2000
- 2000-11-20 US US09/717,703 patent/US6620802B1/en not_active Expired - Lifetime
- 2000-11-21 CA CA2389570A patent/CA2389570C/en not_active Expired - Lifetime
- 2000-11-21 HK HK02108738.8A patent/HK1047050A1/zh unknown
- 2000-11-21 WO PCT/US2000/032260 patent/WO2001037840A1/en not_active Ceased
- 2000-11-21 AU AU19283/01A patent/AU778090B2/en not_active Expired
- 2000-11-21 EP EP00982226A patent/EP1242094A4/en not_active Ceased
- 2000-11-21 JP JP2001539455A patent/JP2003527342A/ja active Pending
-
2003
- 2003-07-28 US US10/628,724 patent/US20040019028A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003527342A5 (https=) | ||
| AU747956B2 (en) | Methods for treating psychosis associated with glucocorticoid related dysfunction | |
| JP2003505336A5 (https=) | ||
| JP2001518509A5 (https=) | ||
| RU99120072A (ru) | Способ и композиция для профилактики и задержки начала болезни Альцгеймера | |
| AU726091B2 (en) | Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen | |
| US5747480A (en) | Oral contraceptive | |
| CA2440605A1 (en) | Methods for treating stress disorders using glucocorticoid receptor-specific antagonists | |
| CA2454339A1 (en) | Methods for preventing antipsychotic-induced weight gain | |
| CA2389570A1 (en) | Methods for treating mild cognitive impairment | |
| JP2006508951A5 (https=) | ||
| CA2504697A1 (en) | Methods for treating migraine | |
| JP2005535664A5 (https=) | ||
| JP2006507311A5 (https=) | ||
| CA2459033A1 (en) | Methods for inhibiting cognitive deterioration in adults with down's syndrome | |
| JPH07278017A (ja) | 麻薬又は麻薬混合物からの自然の又は早められた退薬症状と関連した徴候を予防し又は治療するための薬剤の製造への抗グルココルチコイド活性を有する化合物の使用及びそれらを含有する組成物 | |
| EP0921804B1 (en) | Biphasic oral contraceptive method and kit comprising a combination of a progestin and estrogen | |
| CA2561839C (en) | Multi-phase contraceptive preparation based on a natural estrogen | |
| Baulieu | A novel approach to human fertility control: contragestion by the anti-progesterone RU 486 | |
| JP2005512949A5 (https=) | ||
| CA2532594A1 (en) | Antiglucocorticoids for the treatment of catatonia | |
| CA2446506A1 (en) | Methods for treating delirium using glucocorticoid receptor-specific antagonists | |
| Mazer | Omalizumab reduced inhaled corticosteroid use and exacerbations in childhood allergic asthma | |
| EP1726307A2 (en) | Methods for treating psychosis associated with glucocorticoid related dysfunction | |
| HK1022843B (en) | Monophasic oral contraceptive method and kit comprising a combination of progestin and estrogen |